In conflict-affected populations, PTSD patients who responded to NET exhibited increased methylation at specific NR3C1 CpG sites after therapy, and these changes were correlated with clinical improvement in PTSD symptoms [199]. This evidence concerns the gene NR3C1 and post-traumatic stress disorder.